WATSON 841 (Bisoprolol fumarate and hydrochlorothiazide 2.5 mg / 6.25 mg)
Pill imprint WATSON 841 has been identified as Bisoprolol fumarate and hydrochlorothiazide 2.5 mg / 6.25 mg.
Bisoprolol/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class beta blockers with thiazides. Risk cannot be ruled out during pregnancy. Bisoprolol/hydrochlorothiazide 2.5 mg / 6.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WATSON 841
- 2.5 mg / 6.25 mg
- Prescription only
- Drug Class:
- Beta blockers with thiazides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
|NDC Code||Manufacturer / Repackager|
|00490-0053||Southwood Pharmaceuticals Inc (repackager)|
|23490-7861||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about bisoprolol/hydrochlorothiazide
- Hydrochlorothiazide and bisoprolol
- Bisoprolol and hydrochlorothiazide (Advanced Reading)
- Other brands: Ziac
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.